Clinical Trials Browser

Urinary Bladder Neoplasms

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

VIABLE

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

CONQUER

CARE

Use of Wearables Following Cystectomy- Part II

CaRe

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

SPARC

Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

RAISE02

Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients

GRID®